Low-dose recombinant interleukin-2 therapy in advanced multiple myeloma.
Peest D, Leo R, Bloche S, Hein R, Stannat-Kiessling S, Tschechne B, Fett W, Harms P, Hoffmann L, Bartl R, et al.
Peest D, et al. Among authors: bartl r.
Br J Haematol. 1995 Feb;89(2):328-37. doi: 10.1111/j.1365-2141.1995.tb03308.x.
Br J Haematol. 1995.
PMID: 7873383
Clinical Trial.